InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Robbins Andrew R. Director active across 2 companies, notably Harpoon Therapeutics, Inc.. Aggregated, 4 disclosures have been logged. Activity tracked since 27 November 2023. The latest transaction was disclosed on 19 May 2026 (Don). Regulator: SEC (Form 4). All data is accessible without signup.
4 of 4 declarations